# Long QT Syndrome Screening in Newborns

Study · id `cardio:ct-nct02412709` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02412709](<https://clinicaltrials.gov/study/NCT02412709>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02412709

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 4000 participants.

## Technical summary

Registry record NCT02412709. Randomized; no masking; primary purpose screening. Start 2015-06 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Phase 2
- Enrolled: 4000 participants (planned count; ClinicalTrials.gov record NCT02412709, source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)
- Start date: 2015-06 (registry gives no type) (ClinicalTrials.gov record NCT02412709, source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)
- Primary completion: 2016-12 (anticipated) (ClinicalTrials.gov record NCT02412709, source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)
- Completion: 2017-03 (anticipated) (ClinicalTrials.gov record NCT02412709, source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02412709, source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02412709-2016-09-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Long QT Syndrome Screening in Newborns
- Condition: Long QT Syndrome
- Intervention (Device): QTScreen ECG Recorder
- Lead sponsor: QT Medical, Inc.
- Lead sponsor class: OTHER
- Collaborator: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Collaborator class: OTHER
- Collaborator: University of California, Irvine
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as a collaborator: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (`cardio:org-lundquist-institute-for-biomedical-innovation-at-harbor-439991`)

## Provenance

Content hash: 2a5a7accfc5e5353517321a7444791933176dae9dbed70d6b4a56b13cf042a94
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
